The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Abstract
Many important decisions on hypertension management must currently be taken without the support of evidence \nfrom large randomized controlled trials. The following issues appear in urgent need to be approached by simply \ndesigned trials. \n(1) Should antihypertensive drugs be prescribed to all patients with grade 1 hypertension, even when total \ncardiovascular risk is relatively low or moderate? Because of the very low rate of cardiovascular events \nexpected in these patients, a placebo-controlled trial using intermediate endpoints such as signs of organ \ndamage of recognized prognostic importance would be feasible, ethical, and clinically relevant. \n(2) Should antihypertensive drugs be prescribed to the elderly with grade 1 hypertension, and should antihypertensive \ntreatment achieve a goal of below 140/90mmHg also in the elderly? These trials could make use \nof hard cardiovascular outcomes and could be placebo-controlled. \n(3) Should antihypertensive drug treatment be started in diabetic patients or in patients with previous cerebrovascular \nor cardiovascular disease when BP is still in the high normal level, and should BP goal be below 130/ \n80mmHg in these patients? These issues can be approached by placebo-controlled trials because no trial \nevidence is still available on the benefit of lowering high normal BP or of achieving BP goals below 130/ \n80mmHg. \n(4) What are the lowest safe BP values to achieve by treatment in different clinical conditions? This issue should \nbe approached by trials comparing more or less intense BP-lowering treatment strategies in patients with \ndifferent cardiovascular risk levels. \n(5) Are lifestyle measures known to reduce BP also capable of reducing morbidity and mortality in hypertension? \nA controlled randomized trial using intermediate endpoints (organ damage) would be feasible and desirable \nin patients with high normal BP or grade 1 hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nakao, N., Yoshimura, A., Morita, H., Takada, M., Kayano, T., & Ideura, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12229-5 · Cited by 970
RetractedChobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,594
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Expert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077
Self-citationLewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationHansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Self-citationLevy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationEstimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Sever, P. S., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,782
Self-citation(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
(2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00001 · Cited by 3,027
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Self-citationDahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67185-1 · Cited by 2,909
Self-citationLaw, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Mancia, G., Rosei, E. A., Cífková, R., DeBacker, G., Erdine, S. E., Fagard, R., Farsang, C., Heagerty, A. M., Kawecka-Jaszcs, K., Kiowski, W., et al. (2003) · Lirias · doi:10.1097/01.hjh.0000059051.65882.32 · Cited by 2,601
Self-citationJulius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
Self-citationPfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-5-345 · Cited by 2,366
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
Jamerson, K., Weber, M. A., Bakris, G. L., Dahlöf, B., Pitt, B., Shi, V., Hester, A., Gupte, J., Gatlin, M., & Velazquez, E. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806182 · Cited by 2,065
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,974
Irbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,881
Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Self-citationA strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
AMERY, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,476
Lithell, H., Hansson, L., Skoog, I., Elmfeldt, D., Hofman, A., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,409
Self-citationon behalf of The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension, Ogihara, T., Kikuchi, K., Matsuoka, H., Fujita, T., Higaki, J., Horiuchi, M., Imai, Y., Imaizumi, T., Ito, S., et al. (2014) · Hypertension Research · doi:10.1038/hr.2014.68 · Cited by 1,385
Ray, K. K., Seshasai, S. R. K., Wijesuriya, S., Sivakumaran, R., Nethercott, S., Preiss, D., Erqou, S., & Sattar, N. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60697-8 · Cited by 1,383
Medical Research Council trial of treatment of hypertension in older adults: principal results.
Peart, S., Brennan, P. J., Broughton, P., Dollery, C. T., Hudson, M. F., Lever, A. F., Meade, T. W., Rose, G., & Pocock, S. (1992) · Cited by 1,360
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2998 · Cited by 1,331
Pepine, C. J., Handberg, E. M., Cooper-DeHoff, R. M., Marks, R. G., Kowey, P., Messerli, F. H., Mancia, G., Cangiano, J. L., Garcia-Barreto, D., Keltai, M., et al. (2003) · JAMA · doi:10.1001/jama.290.21.2805 · Cited by 1,286
Self-citationNissen, S. E., Tuzcu, E. M., Libby, P., Thompson, P. D., Ghali, M., Garza, D., Berman, L., Shi, H., Buebendorf, E., Topol, E. J., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2217 · Cited by 1,154
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa042739 · Cited by 1,123
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis
Bangalore, S., Kamalakkannan, G., Parkar, S., & Messerli, F. H. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.08.033 · Cited by 1,075
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
Elliott, W. J., & Meyer, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60108-1 · Cited by 1,016
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
Psaty, B. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080036038 · Cited by 1,003
Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis
Lindholm, L. H., Carlberg, B., & Samuelsson, O. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67573-3 · Cited by 999
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Self-citationEffects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Tuomilehto, J., Rastenyte, D., Birkenhäger, W. H., Thijs, L., Antikainen, R., Bulpitt, C. J., Fletcher, A. E., Forette, F., Goldhaber, A., Palatini, P., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400902 · Cited by 940
Self-citationWald, D. S., Law, M., Morris, J. K., Bestwick, J. P., & Wald, N. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.038 · Cited by 938
Curb, J. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540230036032 · Cited by 930
Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker
Julius, S., Nesbitt, S. D., Egan, B. M., Weber, M. A., Michelson, E. L., Kaciroti, N., Black, H. R., Grimm, R. H., Messerli, F. H., Oparil, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060838 · Cited by 924
Yeboah, J., Crouse, J. R., Hsu, F.-C., Burke, G. L., & Herrington, D. M. (2007) · Circulation · doi:10.1161/circulationaha.106.678276 · Cited by 891
Prognostic Significance of Left Ventricular Mass Change During Treatment of Hypertension
Devereux, R. B. (2004) · JAMA · doi:10.1001/jama.292.19.2350 · Cited by 881
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Schrier, R. W., Estacio, R. O., Esler, A., & Mehler, P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00213.x · Cited by 851
Solomon, S. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92136-9 · Cited by 844
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency
Culleton, B. F., Larson, M. G., Wilson, P. W. F., Evans, J. C., Parfrey, P. S., & Levy, D. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00773.x · Cited by 838
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826
Self-citationViberti, G., & Wheeldon, N. M. (2002) · Circulation · doi:10.1161/01.cir.0000024416.33113.0a · Cited by 802
Bakris, G. L., Fonseca, V., Katholi, R. E., McGill, J. B., Messerli, F. H., Phillips, R. A., Raskin, P., Wright, J. T., Oakes, R., Lukas, M. A., et al. (2004) · JAMA · doi:10.1001/jama.292.18.2227 · Cited by 792
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804593 · Cited by 785
Messerli, F. H., Mancia, G., Conti, C. R., Hewkin, A. C., Kupfer, S., Champion, A., Kolloch, R., Benetos, A., & Pepine, C. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00005 · Cited by 779
Self-citationPeters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., Waldman, A., Walton, I., Poulter, R., Ma, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70143-1 · Cited by 770
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
Klingbeil, A. U., Schneider, M., Martus, P., Messerli, F. H., & Schmieder, R. E. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00158-x · Cited by 761
Self-citationRosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 757
Ärnlöv, J., Evans, J. C., Meigs, J. B., Wang, T. J., Fox, C. S., Levy, D., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.538132 · Cited by 736
Liu, L., Wang, J. G., Gong, L., Liu, G., & Staessen, J. A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00016 · Cited by 730
Randomised trial of treatment of hypertension in elderly patients in primary care.
Coope, J., & Warrender, T. S. (1986) · BMJ · doi:10.1136/bmj.293.6555.1145 · Cited by 725
Barr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D. J., Dunstan, D. W., Cameron, A. J., Dwyer, T., Taylor, H. R., Tonkin, A. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685628 · Cited by 719
Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 717
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 705
(2000) · PubMed · Cited by 691
Madrid, A. H., Bueno, M. G., Rebollo, J. M. G., Marín, I., Peña, G., Bernal, E., Rodriguez, A., Cano, L., Cano, J. M., Cabeza, P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000022665.18619.83 · Cited by 685
Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical Events
Pitt, B., Byington, R. P., Furberg, C. D., Hunninghake, D. B., Mancini, G. B. J., Miller, M. E., Riley, W., & (for the PREVENT Investigators) (2000) · Circulation · doi:10.1161/01.cir.102.13.1503 · Cited by 669
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Buse, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.003 · Cited by 661
The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors
Schrader, J., Lüders, S., Kulschewski, A., Berger, J., Zidek, W., Treib, J., Einhäupl, K., Diener, H. C., & Dominiak, P. (2003) · Stroke · doi:10.1161/01.str.0000075777.18006.89 · Cited by 652
Treatment of mild hypertension: A five year controlled drug trial
Helgeland, A. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90438-6 · Cited by 638
Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials
Gueyffier, F., Bulpitt, C., Boissel, J.-P., Schron, E., Ekbom, T., Fagard, R., Casiglia, E., Kerlikowske, K., & Coope, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08127-6 · Cited by 632
Self-citationWeber, M. A., Julius, S., Kjeldsen, S. E., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16456-8 · Cited by 591
Self-citationVermes, E., Tardif, J.-C., Bourassa, M. G., Racine, N., Levesque, S., White, M., Guerra, P. G., & Ducharme, A. (2003) · Circulation · doi:10.1161/01.cir.0000072793.81076.d4 · Cited by 578
Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154082.72286.2a · Cited by 562
Self-citationThe Australian therapeutic trial in mild hypertension.
Abernethy, J. D. (1984) · Hypertension · doi:10.1161/01.hyp.6.5.774 · Cited by 516
Zanchetti, A., Bond, M. G., Hennig, M., Neiss, A., Mancia, G., Dal Palù, C., Hansson, L., Magnani, B., Rahn, K.-H., Reid, J. L., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039288.86470.dd · Cited by 514
Self-citationPoole-Wilson, P. A., Lubsen, J., Kirwan, B.-A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16980-8 · Cited by 511
RUILOPE, L. M., SALVETTI, A., JAMERSON, K., HANSSON, L., WARNOLD, I., WEDEL, H., & ZANCHETTI, A. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122218 · Cited by 504
Self-citationWilliams, K. J., & Tabas, I. (2006) · Circulation · doi:10.1161/circulationaha.105.606962 · Cited by 486
Klein, R. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010243030 · Cited by 470
First-line drugs for hypertension
Wright, J. M., Musini, V. M., & Gill, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001841.pub3 · Cited by 452
Chaturvedi, N., Porta, M., Klein, R., Orchard, T., Fuller, J., Parving, H. H., Bilous, R., & Sjølie, A. K. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61412-9 · Cited by 451
Gardner, R. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.005 · Cited by 448
Valsartan for prevention of recurrent atrial fibrillation
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805710 · Cited by 441
Verdecchia, P., Staessen, J. A., Angeli, F., de Simone, G., Achilli, A., Ganau, A., Mureddu, G., Pede, S., Maggioni, A. P., Lucci, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61340-4 · Cited by 434
Heerspink, H. J. L., Ninomiya, T., Zoungas, S., de Zeeuw, D., Grobbee, D. E., Jardine, M. J., Gallagher, M., Roberts, M. A., Cass, A., Neal, B., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60212-9 · Cited by 430
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Borch-Johnsen, K. (2000) · Hypertension · doi:10.1161/01.hyp.35.4.898 · Cited by 425
Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw, D., Parving, H.-H., & Henning, R. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050517 · Cited by 399
JATOS Study Group (2008) · Hypertension Research · doi:10.1291/hypres.31.2115 · Cited by 397
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.11.1631 · Cited by 395
Liu, L., Zhang, Y., Liu, G., Li, W., Zhang, X., & Zanchetti, A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000194120.42722.ac · Cited by 392
Self-citationTwo decades of progress in preventing vascular disease
Yusuf, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09358-3 · Cited by 385
Pohl, M. A., Blumenthal, S., Cordonnier, D. J., De Alvaro, F., DeFerrari, G., Eisner, G., Esmatjes, E., Gilbert, R. E., Hunsicker, L. G., de Faria, J. B. L., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110919 · Cited by 375
Assessing Glycemia in Diabetes Using Self-monitoring Blood Glucose and Hemoglobin A 1c
Saudek, C. D., Derr, R. L., & Kalyani, R. R. (2006) · JAMA · doi:10.1001/jama.295.14.1688 · Cited by 373
Atkins, R. C., Briganti, E. M., Lewis, J. B., Hunsicker, L. G., Braden, G., Champion de Crespigny, P. J., DeFerrari, G., Drury, P., Locatelli, F., Wiegmann, T. B., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.10.019 · Cited by 367
Wang, K.-L., Cheng, H.-M., Chuang, S.-Y., Spurgeon, H. A., Ting, C.-T., Lakatta, E. G., Yin, F. C., Chou, P., & Chen, C.-H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283220ea4 · Cited by 362
(2007) · Obstructive Sleep Apnea: Pathophysiology, Comorbidities and Consequences · doi:10.3109/9781420020458-18 · Cited by 361
Ducharme, A., Swedberg, K., Pfeffer, M. A., Cohen-Solal, A., Granger, C. B., Maggioni, A. P., Michelson, E. L., McMurray, J. J. V., Olsson, L., Rouleau, J. L., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.06.036 · Cited by 352
Sleight, P., Redon, J., Verdecchia, P., Mancia, G., Gao, P., Fagard, R., Schumacher, H., Weber, M., Böhm, M., Williams, B., et al. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832d7370 · Cited by 352
Self-citationThe ACE Inhibitors in Diabetic Nephropathy Trialist Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-5-200103060-00009 · Cited by 343
Verdecchia, P., Reboldi, G., Angeli, F., Gattobigio, R., Bentivoglio, M., Thijs, L., Staessen, J. A., & Porcellati, C. (2005) · Hypertension · doi:10.1161/01.hyp.0000174591.42889.a2 · Cited by 338
Hypertension Detection and Follow-up Program Cooperative Group* (1982) · New England Journal of Medicine · doi:10.1056/nejm198210143071603 · Cited by 338
Weber, M. A., Black, H., Bakris, G., Krum, H., Linas, S., Weiss, R., Linseman, J. V., Wiens, B. L., Warren, M. S., & Lindholm, L. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61500-2 · Cited by 334
(1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03270300059008 · Cited by 334
Sarafidis, P. A., & Bakris, G. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.036 · Cited by 332
Potter, J. F., Robinson, T. G., Ford, G. A., Mistri, A., James, M., Chernova, J., & Jagger, C. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70263-1 · Cited by 331
Valsartan for Prevention of Recurrent Atrial Fibrillation
(2009) · New England Journal of Medicine · doi:10.1056/nejmx090019 · Cited by 328
Arima, H., Chalmers, J., Woodward, M., Anderson, C., Rodgers, A., Davis, S., MacMahon, S., & Neal, B. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226212.34055.86 · Cited by 327
Kostis, J. B., Wilson, A. C., Freudenberger, R. S., Cosgrove, N. M., Pressel, S. L., & Davis, B. R. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.059 · Cited by 325
Berl, T., Hunsicker, L. G., Lewis, J. B., Pfeffer, M. A., Porush, J. G., Rouleau, J.-L., Drury, P. L., Esmatjes, E., Hricik, D., Pohl, M., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090763 · Cited by 322
Zanchetti, A., Grassi, G., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832aa6b5 · Cited by 305
Self-citationEijkelkamp, W. B. A., Zhang, Z., Remuzzi, G., Parving, H.-H., Cooper, M. E., Keane, W. F., Shahinfar, S., Gleim, G. W., Weir, M. R., Brenner, B. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050445 · Cited by 302
Solomon, S. D., Appelbaum, E., Manning, W. J., Verma, A., Berglund, T., Lukashevich, V., Cherif Papst, C., Smith, B. A., & Dahlöf, B. (2009) · Circulation · doi:10.1161/circulationaha.108.826214 · Cited by 301
Chaturvedi, N. (2001) · UCL Discovery (University College London) · Cited by 299
Results of the pilot study for the Hypertension in the Very Elderly Trial
Bulpitt, C. J., Beckett, N. S., Cooke, J., Dumitrascu, D. L., Gil-Extremera, B., Nachev, C., Nunes, M., Peters, R., Staessen, J. A., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200312000-00030 · Cited by 296
AUTONOMIC FAILURE: A TEXTBOOK OF CLINICAL DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM.
van Dijk, D. J. G. (2000) · Brain · doi:10.1093/brain/123.9.1972 · Cited by 296
Ueng, K. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.014 · Cited by 293
New-onset diabetes and antihypertensive drugs
Mancia, G., Grassi, G., & Zanchetti, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000194119.42722.21 · Cited by 293
Self-citationBangalore, S., Parkar, S., Grossman, E., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.05.057 · Cited by 290
Boutitie, F., Gueyffier, F., Pocock, S., Fagard, R., Boissel, J. P., & for the INDANA Project Steering Committee (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-6-200203190-00007 · Cited by 287
Self-citationVillamil, A., Chrysant, S. G., Calhoun, D., Schober, B., Hsu, H., Matrisciano-Dimichino, L., & Zhang, J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280103a6b · Cited by 285
Kearney-Schwartz, A., Rossignol, P., Bracard, S., Felblinger, J., Fay, R., Boivin, J.-M., Lecompte, T., Lacolley, P., Benetos, A., & Zannad, F. (2009) · Stroke · doi:10.1161/strokeaha.108.532853 · Cited by 274
Jankowski, P., Kawecka-Jaszcz, K., Czarnecka, D., Brzozowska-Kiszka, M., Styczkiewicz, K., Loster, M., Kloch-Badełek, M., Wiliński, J., Curyło, A. M., & Dudek, D. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.101725 · Cited by 274
Long‐Term Survival and Use of Antihypertensive Medications in Older Persons
Pahor, M., Guralnik, J. M., Corti, M., Foley, D. J., Carbonin, P., & Havlik, R. J. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07393.x · Cited by 272
Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
de Galan, B. E., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C.-E., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070667 · Cited by 271
Self-citationOkin, P. M., Wachtell, K., Devereux, R. B., Harris, K. E., Jern, S., Kjeldsen, S. E., Julius, S., Lindholm, L. H., Nieminen, M. S., Edelman, J. M., et al. (2006) · JAMA · doi:10.1001/jama.296.10.1242 · Cited by 270
Self-citationSystolic and diastolic blood pressure control in antihypertensive drug trials
Mancia, G., & Grassi, G. (2002) · Journal of Hypertension · doi:10.1097/00004872-200208000-00001 · Cited by 266
Self-citationMortality in Patients of the Glasgow Blood Pressure Clinic
Isles, C. G., Walker, L. M., Beevers, G. D., Brown, I., Cameron, H. L., Clarke, J., Hawthorne, V., Hole, D., Lever, A. F., Robertson, J. W. K., et al. (1986) · Journal of Hypertension · doi:10.1097/00004872-198604000-00003 · Cited by 261
Okin, P. M., Devereux, R. B., Jern, S., Kjeldsen, S. E., Julius, S., Nieminen, M. S., Snapinn, S., Harris, K. E., Aurup, P., Edelman, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083724.28630.c3 · Cited by 257
Self-citationBakris, G. L., Fonseca, V., & Katholi, R. L. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.136 · Cited by 256
Zoungas, S., de Galan, B. E., Ninomiya, T., Grobbee, D., Hamet, P., Heller, S., MacMahon, S., Marre, M., Neal, B., Patel, A., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0959 · Cited by 256
Renin inhibition with aliskiren: where are we now, and where are we going?
Azizi, M., Webb, R., Nussberger, J., & Hollenberg, N. K. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202812.72341.99 · Cited by 253
Mancia, G., Bombelli, M., Corrao, G., Facchetti, R., Madotto, F., Giannattasio, C., Trevano, F. Q., Grassi, G., Zanchetti, A., & Sega, R. (2007) · Hypertension · doi:10.1161/01.hyp.0000251933.22091.24 · Cited by 252
Self-citationTurnbull, F., Woodward, M., Neal, B., Barzi, F., Ninomiya, T., Chalmers, J., Perkovic, V., Li, N., MacMahon, S., & the Blood Pressure Lowering Treatment Trialists' Collaboration (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn427 · Cited by 252
Strauss, M. H., & Hall, A. S. (2006) · Circulation · doi:10.1161/circulationaha.105.594986 · Cited by 249
Corrao, G., Zambon, A., Parodi, A., Poluzzi, E., Baldi, I., Merlino, L., Cesana, G., & Mancia, G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f4edd7 · Cited by 236
Self-citationSchmieder, R. E., Kjeldsen, S. E., Julius, S., McInnes, G. T., Zanchetti, A., & Hua, T. A. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f35c67 · Cited by 231
Self-citationBoutouyrie, P., Bussy, C., Hayoz, D., Hengstler, J., Dartois, N., Laloux, B., Brunner, H., & Laurent, S. (2000) · Circulation · doi:10.1161/01.cir.101.22.2601 · Cited by 231
Self-citationLüders, S., Schrader, J., Berger, J., Unger, T., Zidek, W., Böhm, M., Middeke, M., Motz, W., Lübcke, C., Gansz, A., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ff8864 · Cited by 229
Self-citationRelation of Beta-Blocker–Induced Heart Rate Lowering and Cardioprotection in Hypertension
Bangalore, S., Sawhney, S., & Messerli, F. H. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.048 · Cited by 222
Gerdts, E., Wachtell, K., Omvik, P., Otterstad, J. E., Oikarinen, L., Boman, K., Dahlöf, B., & Devereux, R. B. (2007) · Hypertension · doi:10.1161/01.hyp.0000254322.96189.85 · Cited by 221
Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., Boden-Albala, B., Sacco, R., & Homma, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.005 · Cited by 219
Large and Small Artery Cross-Talk and Recent Morbidity-Mortality Trials in Hypertension
Laurent, S., Briet, M., & Boutouyrie, P. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.133116 · Cited by 217
Self-citationAngiotensin receptor blockers and myocardial infarction
Verma, S., & Strauss, M. (2004) · BMJ · doi:10.1136/bmj.329.7477.1248 · Cited by 210
Mancia, G., Messerli, F., Bakris, G., Zhou, Q., Champion, A., & Pepine, C. J. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.090290 · Cited by 210
Self-citationPolese, A., De Cesare, N., Montorsi, P., Fabbiocchi, F., Guazzi, M., Loaldi, A., & Guazzi, M. D. (1991) · Circulation · doi:10.1161/01.cir.83.3.845 · Cited by 207
Change in Blood Pressure and Incident Dementia: A 32-Year Prospective Study
Stewart, R., Xue, Q.-L., Masaki, K., Petrovitch, H., Ross, G. W., White, L. R., & Launer, L. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.128744 · Cited by 205
O’Brien, E., Barton, J., Nussberger, J., Mulcahy, D., Jensen, C., Dicker, P., & Stanton, A. (2007) · Hypertension · doi:10.1161/01.hyp.0000253780.36691.4f · Cited by 199
A comparison of atenolol and nebivolol in isolated systolic hypertension
Dhakam, Z., Yasmin, McEniery, C. M., Burton, T., Brown, M. J., & Wilkinson, I. B. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f283c9 · Cited by 197
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Mann, J. F. E., Schmieder, R. E., Dyal, L., McQueen, M. J., Schumacher, H., Pogue, J., Wang, X., Probstfield, J. L., Avezum, A., Cardona-Munoz, E., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00122 · Cited by 196
Self-citationSchiffrin, E. L., & Deng, L.-Y. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.699 · Cited by 192
Celik, T., Iyisoy, A., Kursaklioglu, H., Kardesoglu, E., Kilic, S., Turhan, H., Yilmaz, M. I., Ozcan, O., Yaman, H., Isik, E., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000209993.26057.de · Cited by 189
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citation(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
Self-citationLv, J., Neal, B., Ehteshami, P., Ninomiya, T., Woodward, M., Rodgers, A., Wang, H., MacMahon, S., Turnbull, F., Hillis, G., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001293 · Cited by 777
Metadata
- Authors
- Mancia, G., Laurent, S., Agabiti-Rosei, E., Ambrosioni, E., Burnier, M., Caulfield, M. J., Cifkova, R., Clément, D., Coca, A., Dominiczak, A., Erdine, S., Fagard, R., Farsang, C., Grassi, G., Haller, H., Heagerty, A., Kjeldsen, S. E., Kiowski, W., Mallion, J. M., Manolis, A., Narkiewicz, K., Nilsson, P., Olsen, M. H., Rahn, K. H., Redon, J., Rodicio, J., Ruilope, L., Schmieder, R. E., Struijker-Boudier, H. A. J., Van Zwieten, P. A., Viigimaa, M., & Zanchetti, A.
- Venue
- Blood Pressure
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 18
- Issue
- 6
- Pages
- 308-347
- ISSN
- 0803-7051 (ISSN-L)
- 1651-1999
- OpenAlex
- W1988716175
- Cited by
- 894
- References
- 305
- FWCI
- 88.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.